z-logo
Premium
Macrophages—proliferation, activation, and cell cycle proteins
Author(s) -
Vadiveloo Peter K.
Publication year - 1999
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1002/jlb.66.4.579
Subject(s) - biology , microbiology and biotechnology , cell cycle , cell growth , cell , immunology , computational biology , biochemistry
Our understanding of mammalian cell proliferation has increased enormously over the past decade. A major advance has been identification and characterization of cyclins and their catalytic partners, cyclin‐dependent kinases (cdks). The following brief review highlights the role of macrophages as a cell model for many of the major advances in this field. Macrophages were central to the identification of D‐type cyclins and cdk4. In addition, it appears the first work showing that cell cycle proteins are the targets for anti‐proliferative agents was performed in macrophages. In these latter studies, and a number of subsequent studies in other cell types, it was shown that many anti‐mitogenic agents repressed cyclin and/or cdk expression. However, recent work in this laboratory suggests macrophage D‐type cyclins may also be involved in processes other than proliferation. We have unexpectedly found that macrophages treated with lipopolysaccharide (LPS) express high levels of cyclin D2, even though LPS simultaneously represses cyclin D1 levels and potently blocks proliferation. These data, and those showing the yeast extract Zymosan A also raises cyclin D2 levels, suggest cyclin D2 plays a role in macrophage activation. J. Leukoc. Biol. 66: 579–582; 1999.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here